Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
  • Alerts
  • Podcasts
  • Subscriptions

Near infrared spectroscopy for the assessment of peripheral tissue oxygenation in pulmonary arterial hypertension

Marios Panagiotou, Ioannis Vogiatzis, Zafeiris Louvaris, Geeshath Jayasekera, Alison MacKenzie, Neil Mcglinchey, Julien S. Baker, Alistair C. Church, Andrew J. Peacock, Martin K. Johnson
European Respiratory Journal 2016 48: 1224-1227; DOI: 10.1183/13993003.01022-2016
Marios Panagiotou
Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mariopanag@gmail.com
Ioannis Vogiatzis
National and Kapodistrian University of Athens, Dept of Physical Education and Sports Sciences, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zafeiris Louvaris
National and Kapodistrian University of Athens, Dept of Physical Education and Sports Sciences, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geeshath Jayasekera
Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison MacKenzie
Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil Mcglinchey
Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julien S. Baker
Institute of Clinical Exercise and Health Science, University of the West of Scotland, Hamilton, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alistair C. Church
Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J. Peacock
Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin K. Johnson
Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Near infrared spectroscopy offers a qualitative, noninvasive indication of mixed venous oxygen saturation in PAH http://ow.ly/TSSx30231YO

To the Editor:

Pulmonary arterial hypertension (PAH) is characterised by increased pulmonary vascular resistance and results in increased morbidity and mortality due to right heart failure and a progressive decline in cardiac output [1, 2]. The latter disturbs oxygen delivery to the periphery and may lead to pathological changes in tissue oxygenation. The balance between global oxygen supply and demand is reflected in mixed venous oxygen saturation (SvO2), an index that is generally reduced in patients with PAH [3]. SvO2 at baseline is one of the strongest predictors of survival in PAH [4–6]; this is also true for changes in SvO2 during follow-up [5]. Cut-off values of 60% [7] and 65% [5] have been used to distinguish between prognostic groups suggesting that these may be suitable treatment goals. SvO2 is measured invasively in the pulmonary artery, where venous blood mixes after circulating through the superior and inferior vena cava, coronary sinuses and the right-heart chambers.

Spatially resolved near infrared spectroscopy (NIRS) offers a noninvasive, rapidly responsive method for measuring skeletal muscle oxygenation by examining absorption differences in the near-infrared spectrum of light between oxy- and deoxy- haemoglobin and myoglobin molecules in the microvasculature. The tissue oxygenation index (StO2) is commonly adopted as an index of the dynamic balance between local tissue oxygen supply (availability) and utilisation (extraction) in both health and disease [8, 9]. Because the contribution of the myoglobin to the NIRS signal is not critical, StO2 is largely considered as the ratio of oxygenated to total tissue haemoglobin concentration expressed as (oxyhaemoglobin/(oxyhaemoglobin+deoxyhaemoglobin))×100%. To evaluate NIRS in PAH, we correlated measurements of StO2 with SvO2 and venous oxygen saturation in the inferior vena cava (SivcO2) during right heart catheterisation.

To measure StO2, one transcutaneous sensor (S-Type Probe, NIRO-200NX spatially resolved spectrophotometer; Hamamatsu Photonics KK, Hamamatsu, Japan) was placed over each vastus lateralis muscle, 10–12 cm above the lateral epicondyle. StO2 values shown are the average values obtained from both legs at the time of concurrent SvO2 and SivcO2 measurements. SvO2 was measured from the distal port of the Swan–Ganz catheter. SivcO2 was measured with a pigtail catheter advanced through the right internal jugular vein sheath to the level of S1 vertebra.

Concurrent, single-point measurements of SvO2 and StO2 were repeated at supine exercise in consecutive patients who consented to this task. One patient performed straight leg raising and nine patients exercised on an electronically braked lower limb cycle ergometer secured to the catheterisation table. Subjects cycled at 60 revolutions·min−1 for 6 min at a constant workload set at 50% of peak work rate achieved during an upright cycle cardiopulmonary exercise test the previous day. SvO2 and StO2 were measured during the sixth minute of exercise. Supplementary oxygen was provided as required to minimise arterial hypoxaemia.

25 subjects with PAH (13 idiopathic PAH; one familial PAH; seven connective tissue disease-associated PAH; one congenital heart disease-associated PAH; three portopulmonary arterial hypertension) were studied at rest, 10 of whom also exercised. Resting mean pulmonary artery pressure, cardiac output and pulmonary vascular resistance were 43±11 mmHg, 4.6±1.7 L·min−1 and 9.5±5.9 Wood units, respectively.

Combining all the resting and exercise data points (n=35), StO2 showed a strong correlation with SvO2 (r=0.703, p<0.001). This level of correlation persisted when looking separately at rest (StO2: 73.1±9.8%, SvO2: 62.5±12.9%; r=0.701, p<0.001) and exercise data (StO2: 69.2±9.2%, SvO2: 42.3±16.6%; r=0.863, p=0.001) (figure 1) but also, the change in StO2 and SvO2 from rest to exercise (r=0.669, p=0.034). A significant reduction was observed in StO2 during exercise (from 77.6±6.9% to 69.2±9.2%; p<0.001). Resting values of StO2 exhibited similar level of correlation with SivcO2 (64.2±14.3%; r=0.655, p=0.001). A strong correlation (r=0.795, p<0.001) was observed between SivcO2 and SvO2, whereas the resting correlations of StO2 with SvO2 and SivcO2 were not statistically different (Z=0.3, p=0.76).

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Patient characteristics and correlations between tissue oxygenation index (StO2) and mixed venous oxygen saturation (SvO2) at a) rest and b) exercise.

Resting StO2 correlated with age (r=−0.416, p=0.038) and indices of disease severity including the 6-min walk distance (r=0.528, p=0.008), N-terminal pro-brain natriuretic peptide (r=−0.395, p=0.05) and diffusing lung capacity for carbon monoxide % predicted (r=0.398, p=0.049).

To our knowledge, this is the first study to report on the association between StO2 and SvO2. Significant correlation between vastus lateralis StO2 and femoral venous oxygen saturation has been reported in healthy trained subjects [10]; although, earlier studies failed to confirm such correlation [11, 12]. However, comparisons should be made with caution as responses of StO2 depend highly on the mode, intensity and duration of exercise and neither of those studies was matched in design to our resting and steady-state exercise protocol. Instead, they reported on measurements either during incremental exercise [10] or over time during constant-load exercise [11, 12].

Nonetheless, the correlation between StO2 and SvO2 or SivcO2 is not absolute and results of relating StO2 to venous blood oxygenation should not be interpreted in a quantitative sense. This may be because the specific tissue volume investigated by NIRS is not fully representative of the oxygen status of the body segment (lower limb) or global tissue oxygenation as measured by SivcO2 and SvO2, respectively [8]. It is not surprising that the highest correlations between StO2 and venous oxygen saturation were shown when the sampled venous effluent was specific for the interrogated tissue volume such as that obtained from a deep forearm vein that drained the exercising human muscle (r=0.92) [9] or from a vein that drained only the electrically simulated canine muscle (r=0.97) [13]. Accordingly, StO2 would be expected to exhibit a higher correlation with SivcO2 than SvO2; however, we observed similar correlations with SivcO2 and SvO2. This seeming paradox may be due to venous return from the lower limbs being the major determinant of SvO2 in the supine leg exercise.

The design of the present study does not allow for reliable conclusions on the tissue oxygen status per se; the presented findings should be interpreted within the context of oxygen supplementation to maintain resting normoxaemia and the absence of a matched control group. However, our findings provide support for the use of NIRS in the investigation of the pathophysiological abnormalities in PAH. Also, taken together, findings cannot exclude a role of the periphery in the pathophysiology of PAH. Indeed, skeletal muscle tissue microenvironment, an important factor of the local oxygen status, is disturbed in PAH [14]. Perhaps, combination of NIRS with other techniques such as vascular occlusion, sidestream dark field imaging and histological examination could enable further exploration.

Limited experience from application of NIRS in PAH showed significantly lower resting thenar muscle oxygen saturation in PAH patients compared to matched healthy subjects and patients with chronic heart failure [15]. Also, study of the kinetics of the vastus lateralis fractional oxygen extraction (% Δ deoxyhaemoglobin/myoglobin) relative to oxygen uptake at the beginning of heavy-intensity exercise, suggested that patients with PAH have greater microvascular oxygen delivery-to-utilisation inequalities compared to healthy controls, which contributes to a slow adaptation rate of aerobic metabolism [16].

In summary, skeletal muscle StO2 in PAH subjects correlated significantly with SvO2 under both resting and exercise conditions. Also, StO2 correlated significantly, albeit weakly, with indices of disease severity. These novel findings suggest that StO2 may serve as a clinical and research tool for the qualitative, noninvasive assessment of the dynamic balance between oxygen supply and utilisation in PAH. Further studies are warranted to explore the value of NIRS in the assessment and prognosis of PAH.

Footnotes

  • Support statement: Marios Panagiotou is the recipient of an ERS PAH Long-Term Research fellowship number LTRF 2014-3106 supported by an unrestricted grant by GSK. Funding information for this article has been deposited with the Open Funder Registry.

  • Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com

  • Received March 24, 2016.
  • Accepted June 13, 2016.
  • Copyright ©ERS 2016

References

  1. ↵
    1. Galie N,
    2. Humbert M,
    3. Vachiery JL, et al.
    2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37: 67–119.
    OpenUrlFREE Full Text
  2. ↵
    1. Galie N,
    2. Humbert M,
    3. Vachiery JL, et al.
    2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015; 46: 903–975.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Kielstein JT,
    2. Bode-Boger SM,
    3. Hesse G, et al.
    Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol 2005; 25: 1414–1418.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Sandoval J,
    2. Bauerle O,
    3. Palomar A, et al.
    Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation 1994; 89: 1733–1744.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Nickel N,
    2. Golpon H,
    3. Greer M, et al.
    The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2012; 39: 589–596.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Wensel R,
    2. Opitz CF,
    3. Anker SD, et al.
    Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002; 106: 319–324.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Higenbottam T,
    2. Butt AY,
    3. McMahon A, et al.
    Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension. Heart 1998; 80: 151–155.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Boushel R,
    2. Langberg H,
    3. Olesen J, et al.
    Monitoring tissue oxygen availability with near infrared spectroscopy (NIRS) in health and disease. Scand J Med Sci Sports 2001; 11: 213–222.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Mancini DM,
    2. Bolinger L,
    3. Li H, et al.
    Validation of near-infrared spectroscopy in humans. J Appl Physiol 1994; 77: 2740–2747.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Vogiatzis I,
    2. Habazettl H,
    3. Louvaris Z, et al.
    A method for assessing heterogeneity of blood flow and metabolism in exercising normal human muscle by near-infrared spectroscopy. J Appl Physiol 2015; 118: 783–793.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Costes F,
    2. Barthelemy JC,
    3. Feasson L, et al.
    Comparison of muscle near-infrared spectroscopy and femoral blood gases during steady-state exercise in humans. J Appl Physiol (1985) 1996; 80: 1345–1350.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. MacDonald MJ,
    2. Tarnopolsky MA,
    3. Green HJ, et al.
    Comparison of femoral blood gases and muscle near-infrared spectroscopy at exercise onset in humans. J Appl Physiol (1985) 1999; 86: 687–693.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Wilson JR,
    2. Mancini DM,
    3. McCully K, et al.
    Noninvasive detection of skeletal muscle underperfusion with near-infrared spectroscopy in patients with heart failure. Circulation 1989; 80: 1668–1674.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Panagiotou M,
    2. Peacock AJ,
    3. Johnson MK
    . Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training? Pulm Circ 2015; 5: 424–434.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Dimopoulos S,
    2. Tzanis G,
    3. Manetos C, et al.
    Peripheral muscle microcirculatory alterations in patients with pulmonary arterial hypertension: a pilot study. Respir Care 2013; 58: 2134–2141.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Barbosa PB,
    2. Ferreira EM,
    3. Arakaki JS, et al.
    Kinetics of skeletal muscle O2 delivery and utilization at the onset of heavy-intensity exercise in pulmonary arterial hypertension. Eur J Appl Physiol 2011; 111: 1851–1861.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 48 Issue 4 Table of Contents
European Respiratory Journal: 48 (4)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Near infrared spectroscopy for the assessment of peripheral tissue oxygenation in pulmonary arterial hypertension
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Near infrared spectroscopy for the assessment of peripheral tissue oxygenation in pulmonary arterial hypertension
Marios Panagiotou, Ioannis Vogiatzis, Zafeiris Louvaris, Geeshath Jayasekera, Alison MacKenzie, Neil Mcglinchey, Julien S. Baker, Alistair C. Church, Andrew J. Peacock, Martin K. Johnson
European Respiratory Journal Oct 2016, 48 (4) 1224-1227; DOI: 10.1183/13993003.01022-2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Near infrared spectroscopy for the assessment of peripheral tissue oxygenation in pulmonary arterial hypertension
Marios Panagiotou, Ioannis Vogiatzis, Zafeiris Louvaris, Geeshath Jayasekera, Alison MacKenzie, Neil Mcglinchey, Julien S. Baker, Alistair C. Church, Andrew J. Peacock, Martin K. Johnson
European Respiratory Journal Oct 2016, 48 (4) 1224-1227; DOI: 10.1183/13993003.01022-2016
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary vascular disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Preliminary data from the ADVENT-HF trial
  • Rate and duration of hospitalisation for acute pulmonary embolism
  • The potential impact of azithromycin in IPF
Show more Agora

Research letters

  • Rate and duration of hospitalisation for acute pulmonary embolism
  • Preliminary data from the ADVENT-HF trial
  • The potential impact of azithromycin in IPF
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Collections
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2019 by the European Respiratory Society